In principle, certainly.
I'll give you one example back, so you may want to tie some numbers to it. There's a specific funding model that exists in both the U.S. and Australia. The U.S. government allocated $750 million four years ago, at $150 million a year, specifically for type 1 research. They did that through the National Institutes of Health, mandating a very specific funding structure for this.
After an announcement late last year, Australia put $30 million for type 1 diabetes in place this year, which was the first time the Australian government specifically funded type 1 diabetes. They have their own medical research council, which is what we used to call CIHR. Instead they are giving $30 million to JDRF.